丹红注射液治疗气滞血瘀证的研究进展

Research Advances in Danhong Injection on Treating Syndrome of Qi Stagnation and Blood Stasis

气滞血瘀证是由气滞导致瘀血内阻而引起的病证,是常见的中医临床病证,临床上血瘀证与心脑血管疾病有一定的关联性,常见的冠心病心绞痛,脑卒中,糖尿病并发症等辨证为气滞血瘀证者为多。治疗血瘀证主要采用活血化瘀法,行气药与活血药有机配伍使活血化瘀作用增强。由丹参和红花组成的中药注射剂-丹红注射液,有活血化瘀,通脉舒络的作用,对瘀血痹阻所致的冠心病,脑卒中及糖尿病并发症从多层面、多靶点出发,对不同的组织器官发挥作用,显示了其治疗气滞血瘀证的有效性和安全性。

The syndrome of qi stagnation and blood stasis is a common clinical syndrome in Traditional Chinese Medicine. The blood stasis is caused by qi stagnation. There is a clinical correlation between blood stasis syndrome and cardiovascular disease. Many of the common diseases such as angina pectoris of coronary heart disease, acute cerebral apoplexy and diabetes are differentiated as syndrome of of qi stagnation and blood stasis. Blood-activating and stasis-dissolving method is the main treatment for blood stasis syndrome. Combining medicine for promoting qi circulation with medicine for activating blood circulation can improve the medicine’s function of activating blood and dissolving stasis. The Danhong injection is composed of radix salvia and safflower. It has the function of activating blood, dissolving stasis and unblocking meridians. In treating diseases caused by blood stasis such ascoronary heart disease, acute cerebral apoplexy and diabetes, it acts on different tissues and organs from multiple aspects and target, which shows the effectiveness and security on treating coronary heart disease, acute cerebral apoplexy and diabetes.